Please find below a video abstract summarising the key findings in the manuscript on home spirometry in patients with idiopathic pulmonary fibrosis in the INMARK trial.

Header - Navigation Icon

The INMARK trial was funded by Boehringer Ingelheim. The authors did not receive payment for development of this manuscript. Writing assistance was provided by Julie Fleming and Wendy Morris of FleishmanHillard Fishburn, London, UK, which was contracted and funded by Boehringer Ingelheim. Boehringer Ingelheim was given the opportunity to review the manuscript for medical and scientific accuracy as well as intellectual property considerations.